Cargando…

Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network

INTRODUCTION: According to the Italian National Report on drug use, thienopyridines (ticlopidine, clopidogrel and prasugrel) and ticagrelor represent the most prescribed antiplatelet agents, beside aspirin. The aim of this study was to analyse the safety profile of these drugs using data from sponta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gozzo, Lucia, Navarria, Andrea, Benfatto, Giuseppe, Longo, Laura, Mansueto, Silvana, Sottosanti, Laura, Pani, Luca, Salomone, Salvatore, Drago, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643364/ https://www.ncbi.nlm.nih.gov/pubmed/28856572 http://dx.doi.org/10.1007/s40261-017-0566-4

Ejemplares similares

39 Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian Pharmacovigilance Database
por: Moretti, Ugo, et al.
Publicado: (2012)

The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
por: Gozzo, Lucia, et al.
Publicado: (2020)

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap
por: Gozzo, Lucia, et al.
Publicado: (2020)

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
por: Gozzo, Lucia, et al.
Publicado: (2020)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
por: Marcucci, Rossella, et al.
Publicado: (2019)

Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees
por: Benfatto, G., et al.
Publicado: (2021)

Correction to: Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees
por: Benfatto, G., et al.
Publicado: (2021)

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
por: Gozzo, Lucia, et al.
Publicado: (2021)

Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue
por: Brancati, Serena, et al.
Publicado: (2021)

Pharmacovigilance and the Italian Medicines Agency
por: Pimpinella, Giuseppe, et al.
Publicado: (2013)

The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries
por: Gozzo, Lucia, et al.
Publicado: (2023)

Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution
por: Gozzo, Lucia, et al.
Publicado: (2022)

Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries
por: Gozzo, Lucia, et al.
Publicado: (2021)

Editorial: Innovative treatments for neuro-psychiatric diseases
por: Gozzo, Lucia, et al.
Publicado: (2023)

Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2020)

Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries
por: Gozzo, Lucia, et al.
Publicado: (2022)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting
por: Lopes, Noemi, et al.
Publicado: (2020)

Pharmacovigilance in practice: erythropoiesis-stimulating agents
por: Hedenus, Michael, et al.
Publicado: (2014)

Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells
por: Bucolo, Claudio, et al.
Publicado: (2012)

Ocular drug delivery: a clue from nanotechnology
por: Bucolo, Claudio, et al.
Publicado: (2012)

Pharmacovigilance in oncology
por: Baldo, Paolo, et al.
Publicado: (2018)

Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
por: Drago, Filippo, et al.
Publicado: (2020)

Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey
por: Stagi, Lisa, et al.
Publicado: (2021)

Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)

A New Era in Pharmacovigilance: Toward Real‐World Data and Digital Monitoring
por: Lavertu, Adam, et al.
Publicado: (2021)

A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data
por: Zhang, Qilin, et al.
Publicado: (2023)

Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
por: Crisafulli, Salvatore, et al.
Publicado: (2023)

New drugs in psychiatry: focus on new pharmacological targets
por: Caraci, Filippo, et al.
Publicado: (2017)

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study
por: Jiang, Lin, et al.
Publicado: (2023)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Patterns of antiplatelet agent use in the US
por: Kanakadandi, Vijay, et al.
Publicado: (2015)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2019)

Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
por: Brancati, Serena, et al.
Publicado: (2021)

Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data
por: Ahmad, Javaria, et al.
Publicado: (2022)

Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study
por: Fabbri, Andrea, et al.
Publicado: (2013)

Newer agents in antiplatelet therapy: a review
por: Yeung, Jennifer, et al.
Publicado: (2012)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cvdkp0ceisdvas5clmaa1asgur